Viral and gene therapy manufacturing site at Carlsbad
- 20 years of experience
- 500 batches of virus to support gene therapy
- single use bioreactor and purification
- phase III and commercial launch (PPQ batch)
- Experience (batches) 2010-2017
- Adeno-associated virus : 19%
- Adenovirus : 20%
- Lentivirus/Retrovirus : 40%
- Reovirus : 5%
- Others : 16%
- in-house process development
- USP : adherent or suspension culture
- DSP
- Technical Transfer
- full tech transfer team for cGMP
- >20 program
- Cell and Viral Banking
- master and working
- cell and viral (access to additional storage in Rockville, Maryland, USA and Glasgow Scotland, UK)
- viral seed stock characterization
- Sterile Fill Finish
- most critical processes in safegarding the sterility
- delivering drug substances intended for use in patient
- 2,000 vials/day in two dedicated Class 1000(ISO 6) fill suites, one of which is designed for commercial fills
- Viral Vector Testing
- Millipore Sigma has a deep understanding on regulatory expectations of safety evaluations of viral vectors
- BioReliance biosafety testing services into our workflow
- Viral vector characterization and testing
- Secure Biostorage
- freezers of -80℃ and -20℃
- liquid nitrogen dewars
- Leader in Viral Vector Mnufacturing
- SAFC Carlsbad
- >20 years of track record in developing and manufacturing viral vectors and vaccines from 1990s
- In 2017 expansion
Bio Reliance (Carlsbad), サンディエゴ、US
関連記事:
[Bio-rAAV] 遺伝⼦治療における代表的な委託製造会社 (CMO) – ID1881 [2021/02/08]
気になる企業 – Vigene Biosciences – GMP準拠のPLCサービス – ID3756 [2020/12/22]
調査 – 遺伝子治療 – LONZAの動向 – ID3803 [2020/05/07]
気になる企業 – Brammer Bio社 – 開発段階 から初期商用製造まで対応可能な豊富な経験を持つ遺伝子治療用の原薬 CDMO – ID11884 [2021/02/24]
気になる企業 – Catalent Biologicsの特徴は、retrovectorを使うGMEx技術による高生産性 -ID12544 [2020/08/05]
気になる企業 – WuXi Advanced Therapies – 遺伝子治療CDMO [2020/06/15]
気になる企業 – Creative Biolabs Inc. はcGMP製造もできるCRO – ID2413 [2020/05/21]
気になる企業 – パセオン(patheon) – ThermoFisherグループ – 抗体/rAAV – ID3631 [2020/08/20]
気になる企業 – バイオCDMO – MabPlex – ADCも可能 – ADCの基礎を学ぶ [2020/07/13]
気になる企業 – Coriolis Pharma – Virus Vector Formulation Development [2010/10/04]